Fasting criteria for screening: test properties and agreement with glucose tolerance

被引:4
作者
Daniel, M
Rowley, KG
O'Dea, K
机构
[1] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Menzies Sch Hlth Res, Darwin, NT, Australia
基金
英国医学研究理事会;
关键词
diabetes mellitus; tests; screening; American Diabetes Association (ADA); World Health Organisation (WHO); diagnostic criteria; indigenous; Australia;
D O I
10.1016/S0168-8227(02)00133-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to characterise test properties and agreement for fasting glucose cut-offs used for screening diabetes in Indigenous Australian communities, across a range of diabetes prevalence. The oral glucose tolerance test (OGTT) was administered to adult volunteers (n = 3249) for community-based diabetes screening in isolated settlements (n = 25). Two-hour post-load glucose concentration was the 'gold standard' against which test properties were characterised for fasting plasma glucose cut-offs at concentrations of greater than or equal to 7.0 mmol/l (ADA criterion) and greater than or equal to 7.8 mmol/l (WHO criterion). Test sensitivity (95% CI) was greater for the ADA (72.5%, 67.4-77.1%) versus the WHO criterion (61.5%, 56.1-66.6%). Specificity was high (> 98%) using either criterion. The post-test likelihood of diabetes, given a population prevalence of 14.8%, was 89.1% using the ADA criterion, and 94.9% using the WHO criterion. The ADA criterion gave better agreement than did the WHO criterion for diabetes prevalence greater than or equal to 8.6%, and the probability of false results was lower using the ADA criterion, when diabetes prevalence was greater than or equal to 12.8%. According to the ADA criterion most individuals ascribed false negative results were aged greater than or equal to 35 years, overweight/obese, or had impaired fasting glucose. The fasting glucose criterion of 7.0 mmol/l was superior to 7.8 mmol/l in screening for diabetes. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 43 条
  • [1] [Anonymous], 1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
  • [2] [Anonymous], HLTH WELFARE AUSTR A
  • [3] Association AD, 2002, DIABETES CARE, V25, ps21, DOI [DOI 10.2337/DIACARE.25.2007.S21, 10.2337/diacare.25.2007.S21]
  • [4] Mid-P confidence intervals: A brief review
    Berry, G
    Armitage, P
    [J]. STATISTICIAN, 1995, 44 (04): : 417 - 423
  • [5] Comparing two diagnostic tests against the same ''gold standard'' in the same sample
    Bloch, DA
    [J]. BIOMETRICS, 1997, 53 (01) : 73 - 85
  • [6] EVALUATION OF FASTING PLASMA-GLUCOSE AS SCREENING-TEST FOR NIDDM IN OLDER ADULTS - RANCHO BERNARDO STUDY
    BLUNT, BA
    BARRETTCONNOR, E
    WINGARD, DL
    [J]. DIABETES CARE, 1991, 14 (11) : 989 - 993
  • [7] CAMERON WI, 1986, DIABETES RES CLIN PR, V2, P304
  • [8] Validity and coverage of estimates of relative accuracy
    Cheng, H
    Macaluso, M
    Hardin, JM
    [J]. ANNALS OF EPIDEMIOLOGY, 2000, 10 (04) : 251 - 260
  • [9] CONNELL FA, 1985, AM J EPIDEMIOL, V121, P744
  • [10] Diabetes incidence in an Australian aboriginal population - An 8-year follow-up study
    Daniel, M
    Rowley, KG
    McDermott, R
    Mylvaganam, A
    O'Dea, K
    [J]. DIABETES CARE, 1999, 22 (12) : 1993 - 1998